Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503906
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-07-17
Brief Title:
Abraxane Avastin and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer
Sponsor:
University of Miami
Organization:
University of Miami
Organization Data
Organization:
University of Miami
Class:
OTHER
Study ID:
20060913
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Miami
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None